Version history
Oncology Nursing Drug Handbook
32
ASO score
Text
49/100
Reviews
0/100
Graphic
40/100
Other
0/100
App Rating
4.8
Votes
656
App Age
7y 8m
Last Update
Apr 17, 2020
iAP
$9.99 - 9.99
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Installs
|
3.8K
|
2.4M
|
-100%
|
|
Rating
|
4.75
|
4.26
|
+12%
|
|
Number of Ratings (Voted)
|
192
|
2.5M
|
-100%
|
|
App Age
|
7y 7m
|
8y 0m
|
-5%
|
|
In-app Purchases Price
|
$10
|
$44
|
-77
%
|
|
Update Frequency
|
2094d
|
180d
|
+1 065%
|
|
Title Length
|
30
|
25
|
+20%
|
|
Short Description Length
|
62
|
62
|
|
|
Description Length
|
1 687
|
2 673
|
-37%
|
|
Number of Screenshots
|
1320
|
1306
|
+1
%
|
|
Has Video?
|
No
|
0% has videos
|
|
|
Size
|
0MB
|
0MB
|
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Jan 02, 2026 | Jan 09, 2026 |
|---|---|---|
|
No results were found!
|
||
| Top | Jan 02, 2026 | Jan 09, 2026 |
|---|---|---|
|
No results were found!
|
||
| Top | Jan 02, 2026 | Jan 09, 2026 |
|---|---|---|
|
No results were found!
|
||
| Top | Jan 02, 2026 | Jan 09, 2026 |
|---|---|---|
|
No results were found!
|
||
Downloads
Downloads Graph
Total
3.8K
Last month
3
Text ASO
Title
(
Characters:
30
of 50
)
Oncology Nursing Drug Handbook
Short Description
(
Characters:
62
of 80
)
Written especially for nurses caring for patients with cancer.
Description
(
Characters:
1687
of 4000
)
Written especially for nurses caring for patients with cancer, the Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
New drugs include:
apalutamide (Erleada™)
calaspargase pegol-mknl (Asparlas™)
Daunorubicin and cytarabine liposome for injection (Vyxeos®)
glucarpidase (Voraxaze®)
alpelisib (Piqray®)
binimetinib (Mektovi®)
dacomitinib (Vizimpro®)
Duvelisib (Copiktra®)
encorafenib (Braftovi®)
erdafitinib (Balversa™)
lorlatinib (Lorbrena®)
anakinra (Kineret®)
baricitinib (Olumiant®)
sarilumab (Kevzara®)
aprepitant injectable emulsion (Cinvanti®)
granisetron hydrochloride extended-release injection (Sustol®)
letermovir (Prevymis™)
omadacycline (Nuzyra™)
meropenem/vaborbactam (Vabomere™)
Plazomicin (Zemdri™)
baloxavir marboxil (Xofluza™)
imipenem/cilastatin sodium/relebactam (Recarbrio™)
eravacycline (Xerava™)
delafloxacin (Baxdela™)}
Read more
Other
Additional Information
| Rating: | |
| Voted: | 656 |
| Google Play Link: | |
| Website: | |
| Email: | |
| Privacy Policy: | |
| Categories: | Medical |
| Size: | - |
| iAP: | 9.99 - 9.99 $ |
| Installs: | 3.77K |
| App Age: | 7 years 8 months |
| Release Date: | May 18, 2018 |
| Last Update: | Apr 17, 2020 |
| Version: | 2.0.1.98 |
Version history
2.0.1.98
Apr 17, 2020
Updated data<br>Framework improvements
0
May 18, 2018
First release